Mereo Biopharma's Potential in Rare Disease Therapy: Buy Rating and Strategic ...

Retrieved on: 2024-12-24 03:51:07

Tags for this article:

Click the tags to see associated articles and topics

Mereo Biopharma's Potential in Rare Disease Therapy: Buy Rating and Strategic .... View article details on hiswai:

Excerpt

Mereo Biopharma Group Plc (MREO) has received a new Buy rating, initiated by LifeSci Capital analyst, Cory Jubinville, PhD.Don't Miss Our Christ.

Article found on: markets.businessinsider.com